Clinical trials
Recherche d’études cliniques
Recherchez uniquement dans les études cliniques enregistrées dans Biomedical Watch.
Études cliniques 3370
| Étude / NCT ⇅ | Molécule ⇅ | Maladie ⇅ | Phase ⇅ | Statut ⇅ | Résultat ⇅ | Sponsor ⇅ | Pays / centres ⇅ | Période ⇅ | Détail |
|---|---|---|---|---|---|---|---|---|---|
| NCT01925196 Natural History and Biomarkers of Amyotrophic Lateral Sclerosis and Fro… |
Natural History and Biomarkers of… | Sclérose latérale amyotrophique | À vérifier | COMPLETED | En attente / non publié | National Institute of Neurologica… | United States · National Institutes of Health Clinica… | 2013-09-30 | Ouvrir |
| NCT06609213 Oral Intake of Enteral Nutrition Formula Preceding Placement and Feedin… |
Oral Intake of Enteral Nutrition … | Sclérose latérale amyotrophique | Non applicable | RECRUITING | En attente / non publié | Andrea Charvet | United States · Nova Southeastern University, Cathy J… | 2025-01-10 → 2026-12 | Ouvrir |
| NCT06147843 FG-CoALS — French-German Cohort Study to Determine Factors Associated W… |
FG-CoALS — French-German Cohort S… | Sclérose latérale amyotrophique | Non applicable | RECRUITING | En attente / non publié | University Hospital, Limoges | France, Germany · CHU de Lille, Lille, France | CHU d… | 2024-09-17 → 2029-09-30 | Ouvrir |
| NCT06266403 Evaluating Verbal Communication in Structured Interactions: Theoretical… |
Evaluating Verbal Communication i… | Sclérose latérale amyotrophique | Non applicable | RECRUITING | En attente / non publié | Penn State University | United States · Speech Core, Pennsylvania State Unive… | 2024-11-05 → 2029-02-28 | Ouvrir |
| NCT07322003 PREVAiLS — Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in… |
Pridopidine | Sclérose latérale amyotrophique | Phase 3 | RECRUITING | En attente / non publié | Prilenia | United States, Belgium, Canada, France, Germany, Irel… | 2026-02-01 → 2029-03 | Ouvrir |
| NCT06119087 Mechanical Insufflation in the Philadelphia Amyotrophic Lateral Scleros… |
Mechanical insufflation | Sclérose latérale amyotrophique | Non applicable | COMPLETED | En attente / non publié | University of Pennsylvania | United States · University of Pennsylvania, Philadelp… | 2024-09-12 → 2026-07-30 | Ouvrir |
| NCT07295990 Tongue-strengthening Exercises in People With ALS. |
Isometric Lingual Strength Exerci… | Sclérose latérale amyotrophique | Non applicable | RECRUITING | En attente / non publié | Nova Southeastern University | United States · Nova Southeastern University, Davie, … | 2026-05-01 → 2029-01 | Ouvrir |
| NCT07223723 A Study to Learn More About the Long-Term Safety of Tofersen (Qalsody) … |
Tofersen | Sclérose latérale amyotrophique | Phase 4 | ACTIVE_NOT_RECRUITING | En attente / non publié | Biogen | China · Peking University Third Hospital, Beijing, Ch… | 2025-12-11 → 2027-05-26 | Ouvrir |
| NCT03225144 Investigating Complex Neurodegenerative Disorders Related to Amyotrophi… |
Investigating Complex Neurodegene… | Sclérose latérale amyotrophique | À vérifier | RECRUITING | En attente / non publié | National Institute of Neurologica… | United States · National Institutes of Health Clinica… | 2017-10-11 → 2027-10-30 | Ouvrir |
| NCT03490539 PROMISE-MG — Disease-Modifying Treatments for Myasthenia Gravis |
Mycophenolate Mofetil | Myasthénie | À vérifier | COMPLETED | En attente / non publié | Children's Hospital Medical Cente… | United States, Canada · Beth Israel Deaconess Medical… | 2018-05-07 → 2021-01-31 | Ouvrir |
| NCT06456580 A Study of Telitacicept for the Treatment of Generalized Myasthenia Gra… |
Telitacicept | Myasthénie | Phase 3 | RECRUITING | En attente / non publié | The Children's Hospital of Zhejia… | United States, Argentina, Australia, Belgium, Brazil,… | 2024-07-17 → 2029-01 | Ouvrir |
| NCT06414954 SYNAPSE-MG — Safety and Efficacy of 3 Dose Levels of NMD670 in Adult Pa… |
NMD670 | Myasthénie | Phase 2 | RECRUITING | En attente / non publié | NMD Pharma A/S | United States, Belgium, Denmark, France, Georgia, Ita… | 2024-05-16 → 2026-12 | Ouvrir |
| NCT07677852 MYAOUS — Sexual and Urinary Dysfunctions in Generalized Myasthenia |
MYAOUS — Sexual and Urinary Dysfu… | Myasthénie | À vérifier | NOT_YET_RECRUITING | En attente / non publié | Centre Hospitalier Universitaire … | France · APHP and Myology institute, Paris, France | … | 2026-07-30 → 2030-07-30 | Ouvrir |
| NCT06743490 CAPTURE - MG — Capturing Key MG-symptoms Using Smartphone Recordings. |
CAPTURE - MG — Capturing Key MG-s… | Myasthénie | À vérifier | RECRUITING | En attente / non publié | Leiden University Medical Center | Netherlands · Leiden University Medical Center, Leide… | 2025-03-18 → 2026-09-30 | Ouvrir |
| NCT06659627 FIT to ACT-MG — Interventions Against Fatigue in Patients With Myasthen… |
FIT to ACT-MG — Interventions Aga… | Myasthénie | Non applicable | ACTIVE_NOT_RECRUITING | En attente / non publié | Leiden University Medical Center | Netherlands · Leiden University Medical Center, Leide… | 2024-12-04 → 2027-01-23 | Ouvrir |
| NCT05070858 NIMBLE — A Study to Test How Safe Pozelimab and Cemdisiran Combination … |
Pozelimab + Cemdisiran | Myasthénie | Phase 3 | ACTIVE_NOT_RECRUITING | En attente / non publié | Regeneron Pharmaceuticals | United States, Belgium, Brazil, Canada, China, Denmar… | 2021-12-14 → 2028-11-11 | Ouvrir |
| NCT07714798 Universal STAR-T Cell Injection in Generalized Myasthenia Gravis |
Universal STAR-T Cell | Myasthénie | Phase 1 | NOT_YET_RECRUITING | En attente / non publié | Daishi Tian | China · Tongji Hospital Affiliated to Tongji Medical … | 2026-07-06 → 2028-07-06 | Ouvrir |
| NCT07717281 PANORAMA: Neuromuscular Organoids for Refractory AChR+ Myasthenia Gravis |
PANORAMA: Neuromuscular Organoids… | Myasthénie | À vérifier | RECRUITING | En attente / non publié | Fondazione IRCCS Ca' Granda, Ospe… | Italy · Fondazione IRCCS Ca' Granda Ospedale Maggiore… | 2026-06-04 → 2028-03-31 | Ouvrir |
| NCT07673627 ADAPT Forward2 — ADAPT Forward 2 - ISA2 - a Study to Evaluate the Safet… |
Empasiprubart IV | Myasthénie | Phase 2 | RECRUITING | En attente / non publié | argenx | United States · Dent Neurologic Institute - Amherst, … | 2026-07-10 → 2028-04 | Ouvrir |
| NCT06282159 A Phase 2 Study to Evaluate DNTH103 in Adults With Generalized Myasthen… |
Claseprubart | Myasthénie | Phase 2 | ACTIVE_NOT_RECRUITING | En attente / non publié | Dianthus Therapeutics | United States, Argentina, Canada, Czechia, Denmark, F… | 2024-02-23 → 2028-10 | Ouvrir |
| NCT04951622 A Study of Nipocalimab Administered to Adults With Generalized Myasthen… |
Nipocalimab | Myasthénie | Phase 3 | RECRUITING | En attente / non publié | Janssen Research & Development, L… | United States, Australia, Belgium, Canada, China, Cze… | 2021-07-15 → 2029-03-29 | Ouvrir |
| NCT06558279 ADAPT oculus — A Study to Assess Efficacy and Safety of Efgartigimod PH… |
Efgartigimod PH20 SC | Myasthénie | Phase 3 | ACTIVE_NOT_RECRUITING | En attente / non publié | argenx | United States, Australia, Austria, Belgium, Canada, C… | 2024-09-18 → 2027-12 | Ouvrir |
| NCT07039916 Study to Assess the Efficacy and Safety of IMVT-1402 in Participants Wi… |
IMVT-1402 | Myasthénie | Phase 3 | RECRUITING | En attente / non publié | Immunovant Sciences GmbH | United States, Argentina, Czechia, Denmark, Georgia, … | 2025-05-27 → 2028-12 | Ouvrir |
| NCT07294170 ADAPT Forward - Master Protocol of a Platform Study to Evaluate the Saf… |
Efgartigimod IV | Myasthénie | À vérifier | RECRUITING | En attente / non publié | argenx | United States, Belgium, Germany, Greece, Italy, Japan… | 2025-12-19 → 2028-03-07 | Ouvrir |
| NCT06435312 ziMyG+ — An Open-label Extension Study to Evaluate Subcutaneous Zilucop… |
Zilucoplan | Myasthénie | Phase 3 | ENROLLING_BY_INVITATION | En attente / non publié | UCB Biopharma SRL | Italy, Poland, South Korea, United Kingdom · Mg0015 2… | 2024-11-19 → 2027-11-19 | Ouvrir |